LMRI · Lumexa Imaging Holdings, Inc. Common Stock

Summary

Lumexa Imaging Holdings, Inc. issued a press release with preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, reporting consolidated revenue growth of 7.9% to $267.7 million and 7.8% to $1.023 billion, respectively, alongside Adjusted EBITDA increases and a leverage reduction to 3.5 times, while reiterating full year 2026 guidance. This provides investors early visibility into performance metrics and future expectations ahead of audited results.

Key takeaways

• Q4 2025 consolidated revenues $267.7 million, up 7.9% from $248.0 million in Q4 2024
• Q4 2025 Adjusted EBITDA $63.8 million, up 18.6% from $53.7 million, 23.8% margin
• FY 2025 consolidated revenues $1.023 billion, up 7.8% from $948.9 million
• FY 2025 Adjusted EBITDA $230.2 million, up 14.6% from $200.8 million, 22.5% margin
• Leverage reduced two turns from 5.5x to 3.5x, yielding over $50 million annual cash savings
• FY 2026 guidance: consolidated revenues $1.045-$1.097 billion, Adjusted EBITDA $234-$242 million